Literature DB >> 24613109

Ammonia levels and the severity of hepatic encephalopathy.

Muhammad Omar Qureshi1, Nasir Khokhar1, Farzana Shafqat1.   

Abstract

OBJECTIVE: To evaluate the correlation between ammonia levels with the severity of HE in patients coming to the tertiary care hospital with liver cirrhosis and hepatic encephalopathy (HE). STUDY
DESIGN: Descriptive, analytical study. PLACE AND DURATION OF STUDY: Shifa International Hospital, Islamabad, from January 2011 to February 2012.
METHODOLOGY: A total of 135 patients with liver cirrhosis and HE had serum ammonia levels measured on admission. The diagnosis of HE was based on clinical criteria, and its severity was graded according to the West Haven Criteria for grading of mental status. Ammonia levels were correlated with the severity of HE using Spearman rank correlation.
RESULTS: Out of 20 patients with normal ammonia levels, 13 (65%) were in HE I-II, 6 (30%) were in grade-III, while 1 (5%) patient was in grade-IV HE. Out of 45 patients with mild hyperammonemia, 27 (60%) were in grade I-II, 12 (26%) were in grade-III and 6 (13%) were in grade-IV HE. Out of 34 patients with moderate hyperammonemia, 9 (26%) were in grade I-II, 18 (53%) were in grade-III, and 7 (20%) were in grade-IV HE. Out of 36 patients with severe hyperammonemia, 31 (86%) patients were in grade-IV HE (p < 0.001).
CONCLUSION: Ammonia levels correlated with the severity of hepatic encephalopathy. Greater the ammonia level, severe is the grade of hepatic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24613109     DOI: 03.2014/JCPSP.160163

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  15 in total

Review 1.  Pathophysiology, diagnosis, and management of hepatic encephalopathy.

Authors:  Christopher Sheasgreen; Lucy Lu; Ameen Patel
Journal:  Inflammopharmacology       Date:  2014-10-10       Impact factor: 4.473

Review 2.  The gut microbiome and the brain.

Authors:  Leo Galland
Journal:  J Med Food       Date:  2014-12       Impact factor: 2.786

3.  Conservative management of severe serotonin syndrome with coma, myoclonus, and crossed-extensor reflex complicated by hepatic encephalopathy.

Authors:  Vignesh Ramachandran; Belicia Ding; Rollin George; Matthew Novakovic
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-02-01

4.  Thrombospondin-1 Exacerbates Acute Liver Failure and Hepatic Encephalopathy Pathology in Mice by Activating Transforming Growth Factor β1.

Authors:  Brandi Jefferson; Malaika Ali; Stephanie Grant; Gabriel Frampton; Michaela Ploof; Sarah Andry; Sharon DeMorrow; Matthew McMillin
Journal:  Am J Pathol       Date:  2019-11-14       Impact factor: 4.307

Review 5.  Hyperammonemia in Hepatic Encephalopathy.

Authors:  A R Jayakumar; Michael D Norenberg
Journal:  J Clin Exp Hepatol       Date:  2018-06-20

6.  Hyperammonemia Is Associated with Increasing Severity of Both Liver Cirrhosis and Hepatic Encephalopathy.

Authors:  Abidullah Khan; Maimoona Ayub; Wazir Mohammad Khan
Journal:  Int J Hepatol       Date:  2016-10-25

Review 7.  Gut Dysbiosis in Animals Due to Environmental Chemical Exposures.

Authors:  Cheryl S Rosenfeld
Journal:  Front Cell Infect Microbiol       Date:  2017-09-08       Impact factor: 5.293

Review 8.  Gut microbiota changes in the extreme decades of human life: a focus on centenarians.

Authors:  Aurelia Santoro; Rita Ostan; Marco Candela; Elena Biagi; Patrizia Brigidi; Miriam Capri; Claudio Franceschi
Journal:  Cell Mol Life Sci       Date:  2017-10-14       Impact factor: 9.261

Review 9.  Mediterranean diet and inflammaging within the hormesis paradigm.

Authors:  Morena Martucci; Rita Ostan; Fiammetta Biondi; Elena Bellavista; Cristina Fabbri; Claudia Bertarelli; Stefano Salvioli; Miriam Capri; Claudio Franceschi; Aurelia Santoro
Journal:  Nutr Rev       Date:  2017-06-01       Impact factor: 7.110

10.  CLIF-SOFA score and SIRS are independent prognostic factors in patients with hepatic encephalopathy due to alcoholic liver cirrhosis.

Authors:  Jin Hee Jeong; In Sung Park; Dong Hoon Kim; Seong Chun Kim; Changwoo Kang; Soo Hoon Lee; Tae Yun Kim; Sang Bong Lee
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.